The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.
about
Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAsMicroRNAs in the Stressed Heart: Sorting the Signal from the NoiseIdentification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseasesmiR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury.miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure.The potential of endurance exercise-derived exosomes to treat metabolic diseases.Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance.Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts.MicroRNAs Mediate Beneficial Effects of Exercise in Heart.Intermittent cardiac overload results in adaptive hypertrophy and provides protection against left ventricular acute pressure overload insult.The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and ChallengesMicroRNAs in heart and circulation during physical exercise
P2860
Q26827482-B5833362-7BBC-4654-A167-E575769E8B89Q26995334-3C375AD3-EE5C-4B70-9CB9-8EA3CF17F17CQ28583018-64DE174E-52BD-4530-AFF1-4E36C63F3214Q36504308-F28F3AF6-6753-4B96-A0B5-D076B1D0E036Q37668558-AE9E141F-D065-493D-B944-F83D6F333562Q38591803-D6F3FBE2-67C8-4C31-9BA6-89A6793EC7AEQ38842507-5A87E759-00CD-480E-83B9-15F209433DFEQ38845636-FCB49905-96EC-4DCB-B16B-EAA73501AB62Q45967235-15068A8F-9C2B-4CC8-81BE-460B2705F213Q48211539-C8AD1423-4BB7-410B-BE27-C17A898CB86DQ49917356-D6838F6C-9D9D-4728-A8F4-A9650A9890FEQ51787118-78932A2A-28DA-4F50-A812-0AC2AF4C5771Q53494009-0AE9238B-169F-4C30-9A5F-DA847003C99EQ54139767-4CE7F31E-2760-4249-BD3E-09CCB3B7D84DQ57300051-16BC0DC5-E8AA-4AD3-A870-88D9671C1BE5Q59132050-CD731EEA-8CD2-4537-BA07-C939F6AD1268
P2860
The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The therapeutic potential of m ...... iological cardiac hypertrophy.
@en
type
label
The therapeutic potential of m ...... iological cardiac hypertrophy.
@en
prefLabel
The therapeutic potential of m ...... iological cardiac hypertrophy.
@en
P2860
P356
P1476
The therapeutic potential of m ...... siological cardiac hypertrophy
@en
P2093
Jenny Y Y Ooi
Julie R McMullen
P2860
P304
P356
10.4155/FMC.13.196
P577
2014-02-01T00:00:00Z